Actavis is a global, integrated specialty pharmaceutical company.
Business Model:
Revenue: $0
Employees: 1,001-5,000
Actavis was acquired by
Teva Pharmaceutical Industries.
The acquisition happend on 2015-07-27.
Details of the transaction were not public
Address:
City: Parsippany
State: New Jersey
Zip:
Country: United States
Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has global headquarters in Dublin, Ireland and Administrative Headquarters in Parsippany, New Jersey, USA. http://www.allergan.com/products/key-products/generic-products
Contact Phone:
Contact Email:
Listed Exchange:
NYSE
IPO Date:
10/2/2013
Ticker Symbol:
ACT
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
1/2015 | Auden McKenzie | |
11/2014 | Allergan | |
10/2014 | Durata Therapeutics | |
4/2014 | Silommedical | |
2/2014 | Forest Laboratories | |
5/2013 | Warner Chilcott |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|